Sign in
Taking people in United StatesNo phase

Follows people with type 1 diabetes after islet transplant graft loss

Observes adults with type 1 diabetes whose islet transplant graft was lost.

Key facts

Who runs it
Rodolfo Alejandro
Where
Miami, United StatesSee the site
Trial code
Registry title
Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
Status
Recruiting
People taking part
60 people, planned
Started
Dec 2008
Expected to end
Jul 2028
Type of study
Observational
Record updated
23 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 1 diabetes who have had an islet-alone transplant and whose transplanted islet cells have stopped working. They are followed over a long time.

Age
18 Years to 75 Years
Sex
All sexes can join.
Disease stage
Type 1 diabetes with islet graft loss after an islet transplant.
Earlier treatment
Must have had at least one islet-alone transplant (an islet transplant without any other organ transplant).

Main reasons for not taking part

  • Cannot give written informed consent
  • Mentally unstable or unable to follow the study procedures
  • History of any solid organ transplant

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • History of at least one islet alone transplant (ie islet transplant in the absence of any other organ transplant)

Who cannot take part

  • History of any solid organ transplant
  • Inability to provide written informed consent
  • Mentally unstable and/or unable to comply with the procedures of the study protocol

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Where in United States

  • Diabetes Research InstituteMiami, United StatesContact: Rodolfo Alejandro, MDTaking people

About the trial

What the trial wants to find out

This is a single-center, prospective, open label study in islet transplant recipients following islet graft loss.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
Plain-language title
Follows people with type 1 diabetes after islet transplant graft lossGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT02000687, who can take part
Publications
Record updated
23 March 2026